Cheminformatics-Based Evaluation of Drug-Likeness in Selected Phytochemicals from Vateria indica (Sarjarasa)

Background

Cheminformatics has emerged as a powerful tool in early-phase drug discovery, enabling the efficient evaluation of bioactive compounds from natural sources. Vateria indica (Sarjarasa), a medicinal plant used in traditional systems, contains a wide array of phytochemicals with various pharmacological activities. Assessing the drug-likeness of these phytochemicals can help identify promising candidates for further development.

Materials and Methods

Phytochemical data were obtained from Computational databases. Selected compounds were analyzed using advanced software to evaluate drug-likeness based on Lipinski’s Rule of Five and other key pharmacokinetic parameters. Cheminformatics techniques were employed to predict bioavailability and assess potential toxicity.

Results and Discussion

Most of the analysed phytochemicals exhibited favourable drug-like properties, including good predicted oral bioavailability and low toxicity. However, compounds such as hopeaphenol and oleoresin turmeric violated multiple parameters of Lipinski’s Rule, indicating potential limitations in oral bioavailability. These outcomes emphasize the variability among natural compounds and highlight the need for careful in silico screening.

Conclusion

The study demonstrates the effectiveness of cheminformatics in evaluating drug-likeness of phytochemicals from Vateria indica (Sarjarasa). While several compounds meet standard drug-likeness criteria, others require structural optimization or alternative delivery approaches. These insights support the role of in silico methods in accelerating natural product-based drug discovery.